ClinicalTrials.govpublic full text
Wuling Powder for the Treatment and Underlying Mechanism of Depressive Symptoms in Patients With Parkinson's Disease
antidepressive agents, parkinson's disease, depression, wuling powder, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1007056
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.